Literature DB >> 12616390

Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter.

W S Richardson1, G W Willis, J W Smith.   

Abstract

BACKGROUND: It has been postulated that nonsurgical treatments for achalasia cause fibrosis, increasing the risk of surgical Heller myotomy. The goal of this study was to evaluate fibrosis, muscle fracture, and esophageal inflammation after these treatments.
METHODS: Eighteen female swine were divided into three groups: 6 were euthanized and their lower esophageal sphincters were harvested (group 1); 6 underwent botulinum toxin injection (group 2); and 6 underwent forced balloon dilatation (group 3). Groups 2 and 3 were euthanized 30 days later and LESs harvested. LESs, were evaluated with trichrome and hematoxylin and eosin (H&E) preparations.
RESULTS: Results for both trichrome and H&amp;E slides were the same: severe inflammation in groups 2 and 3 but only minimal inflammation in group 1 (p <0.05) and mild fibrosis in groups 2 and 3 and none in group 1 (p <0.05).
CONCLUSIONS: Botulinum toxin injection and forced balloon dilatation caused significant inflammation in the esophagus of the swine, which would be consistent with the injury caused by reflux. Forced balloon dilatation and botulinum toxin caused fibrosis and may increase surgical risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616390     DOI: 10.1007/s00464-002-8628-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  15 in total

1.  Does botulinum toxin injection make esophagomyotomy a more difficult operation?

Authors:  S Horgan; K Hudda; T Eubanks; J McAllister; C A Pellegrini
Journal:  Surg Endosc       Date:  1999-06       Impact factor: 4.584

2.  Laparoscopic cardiomyotomy for achalasia after failed balloon dilatation.

Authors:  I J Beckingham; M Callanan; J A Louw; P C Bornman
Journal:  Surg Endosc       Date:  1999-05       Impact factor: 4.584

Review 3.  Surgical management of achalasia.

Authors:  J G Hunter; W S Richardson
Journal:  Surg Clin North Am       Date:  1997-10       Impact factor: 2.741

Review 4.  Pneumatic balloon dilation for esophageal achalasia.

Authors:  S C Kadakia; R K Wong
Journal:  Gastrointest Endosc Clin N Am       Date:  2001-04

5.  Long-term outcome of achalasia treatment: the need for closer follow-up.

Authors:  C F Torbey; E Achkar; T W Rice; M Baker; J E Richter
Journal:  J Clin Gastroenterol       Date:  1999-03       Impact factor: 3.062

6.  A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection.

Authors:  D R Urbach; P D Hansen; Y S Khajanchee; L L Swanstrom
Journal:  J Gastrointest Surg       Date:  2001 Mar-Apr       Impact factor: 3.452

7.  Pneumatic dilation in achalasia with a low-compliance balloon: results of a 5-year prospective evaluation.

Authors:  T Wehrmann; V Jacobi; M Jung; B Lembcke; W F Caspary
Journal:  Gastrointest Endosc       Date:  1995-07       Impact factor: 9.427

8.  Use of high-resolution endoscopic ultrasonography to assess esophageal wall damage after pneumatic dilation and botulinum toxin injection to treat achalasia.

Authors:  T D Schiano; R S Fisher; H P Parkman; S Cohen; M Dabezies; L S Miller
Journal:  Gastrointest Endosc       Date:  1996-08       Impact factor: 9.427

9.  Treatment of achalasia with pneumatic dilatations.

Authors:  G Vantrappen; J Hellemans; W Deloof; P Valembois; J Vandenbroucke
Journal:  Gut       Date:  1971-04       Impact factor: 23.059

10.  Achalasia. A morphologic study of 42 resected specimens.

Authors:  J R Goldblum; R I Whyte; M B Orringer; H D Appelman
Journal:  Am J Surg Pathol       Date:  1994-04       Impact factor: 6.394

View more
  17 in total

1.  Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than heller myotomy alone.

Authors:  C Daniel Smith; Alessandro Stival; D Lee Howell; Vickie Swafford
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

2.  Prevention of post-operative leak following laparoscopic Heller myotomy.

Authors:  Kelly R Finan; David Renton; Catherine C Vick; Mary T Hawn
Journal:  J Gastrointest Surg       Date:  2008-09-10       Impact factor: 3.452

3.  Multiple preoperative endoscopic interventions are associated with worse outcomes after laparoscopic Heller myotomy for achalasia.

Authors:  Christopher W Snyder; Ryan C Burton; Lindsay E Brown; Manasi S Kakade; Kelly R Finan; Mary T Hawn
Journal:  J Gastrointest Surg       Date:  2009-09-30       Impact factor: 3.452

4.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

5.  Guess the case from the ochsner archives.

Authors:  David J Licini; William S Richardson
Journal:  Ochsner J       Date:  2008

Review 6.  Endoscopic botox injections in therapy of refractory gastroparesis.

Authors:  Andrew Ukleja; Kanwarpreet Tandon; Kinchit Shah; Alicia Alvarez
Journal:  World J Gastrointest Endosc       Date:  2015-07-10

7.  Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?

Authors:  Brian E Lacy; Kirsten Weiser; Abigail Kennedy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

8.  Midterm follow-up evaluation after a novel approach to anterior fundoplication for achalasia.

Authors:  W S Richardson; C I Kennedy; J S Bolton
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

9.  Factors affecting quality of life after minimally invasive Heller myotomy for achalasia.

Authors:  Yannis Raftopoulos; Rodney J Landreneau; Fernando Hayetian; Pavlos Papasavas; Keith S Naunheim; Steven R Hazelrigg; Ricardo Santos; Daniel Gagné; Philip Caushaj; Robert J Keenan
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

10.  Therapeutic efficacy of laparoscopic Heller-Dor surgery for chest pain in patients with achalasia: a single institutional experience.

Authors:  Kazuto Tsuboi; Nobuo Omura; Fumiaki Yano; Masato Hoshino; Se-Ryung Yamamoto; Shunsuke Akimoto; Takahiro Masuda; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Esophagus       Date:  2019-10-04       Impact factor: 4.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.